Japonicone A inhibits the growth of non-small cell lung cancer cells via mitochondria-mediated pathways

Tumor Biology

Volumn 36, Issue 10, 2015, Pages 7473-7482

  Du, Yan ^a   Gong, Jiannan ^a   Tian, Xinrui ^a   Yan, Xiaomei ^a   Guo, Tao ^a   Huang, Min ^a   Zhang, Bingtai ^a   Hu, Xiaoyun ^a   Liu, Hui ^a   Wang, Yinping ^a   Li, Jianqiang ^a   Li, Maolan ^a,b,c  

^a SHANXI MEDICAL UNIVERSITY   (China)

^b XINHUA HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Apoptosis; Cell cycle arrest; Japonicone A; Mitochondria mediated pathways; Non small cell lung cancer

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 3; CASPASE 9; CYCLIN D1; CYCLIN DEPENDENT KINASE 2; JAPONICONE A; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN CDC25A; UNCLASSIFIED DRUG; SESQUITERPENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL CYCLE PROGRESSION; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; IN VITRO STUDY; MITOCHONDRION; MOUSE; NON SMALL CELL LUNG CANCER; NONHUMAN; PRIORITY JOURNAL; S PHASE CELL CYCLE CHECKPOINT; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; CARCINOMA, NON-SMALL-CELL LUNG; CELL CYCLE; CELL PROLIFERATION; DRUG EFFECTS; DRUG SCREENING; ENZYME IMMUNOASSAY; LUNG NEOPLASMS; METABOLISM; MITOCHONDRIAL MEMBRANE POTENTIAL; NUDE MOUSE; PATHOLOGY; TUMOR CELL CULTURE; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; CARCINOMA, NON-SMALL-CELL LUNG; CASPASE 3; CASPASE 9; CELL CYCLE; CELL PROLIFERATION; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG NEOPLASMS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MICE, INBRED BALB C; MICE, NUDE; MITOCHONDRIA; POLY(ADP-RIBOSE) POLYMERASES; SESQUITERPENES, EUDESMANE; SESQUITERPENES, GUAIANE; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84944281598     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-015-3439-6     Document Type: Article

References (25)

1. Kumar MS, Armenteros-Monterroso E, East P, Chakravorty P, Matthews N, Winslow MM, et al. HMGA2 functions as a competing endogenous RNA to promote lung cancer progression. Nature. 2014;505:212–7.
2. Al-Shahrabani F, Vallbohmer D, Angenendt S, Knoefel WT. Surgical strategies in the therapy of non-small cell lung cancer. World J of Clin Oncol. 2014;5:595–603.
3. Xiong F, Jiang M, Huang Z, Chen M, Chen K, Zhou J, et al. A novel herbal formula induces cell cycle arrest and apoptosis in association with suppressing the PI3K/AKT pathway in human lung cancer A549 cells. Integr Cancer Ther. 2014;13:152–60.
4. Smith SL, Palma D, Parhar T, Alexander CS, Wai ES. Inoperable early stage non-small cell lung cancer: comorbidity, patterns of care and survival. Lung Cancer. 2011;72:39–44.
5. Paz-Ares LG, Altug S, Vaury AT, Jaime JC, Russo F, Visseren-Grul C. Treatment rationale and study design for a phase III, double-blind, placebo-controlled study of maintenance pemetrexed plus best supportive care versus best supportive care immediately following induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small cell lung cancer. BMC Cancer. 2010;10:85.
6. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.
7. Li X, Yang X, Liu Y, Gong N, Yao W, Chen P, et al. Japonicone A suppresses growth of Burkitt lymphoma cells through its effect on NF-kappaB. Clin Cancer Res. 2013;19:2917–28.
8. Qin JJ, Jin HZ, Fu JJ, Hu XJ, Wang Y, Yan SK, et al. Japonicones A-D, bioactive dimeric sesquiterpenes from Inula japonica Thunb. Bioorg Med Chem Lett. 2009;19:710–3.
9. Hu Z, Qin J, Zhang H, Wang D, Hua Y, Ding J, et al. Japonicone A antagonizes the activity of TNF-alpha by directly targeting this cytokine and selectively disrupting its interaction with TNF receptor-1. Biochem Pharmacol. 2012;84:1482–91.
10. Luscan A, Shackleford G, Masliah-Planchon J, Laurendeau I, Ortonne N, Varin J, et al. The activation of the WNT signaling pathway is a hallmark in neurofibromatosis type 1 tumorigenesis. Clin Cancer Res. 2014;20:358–71.
11. Li HH, Su JH, Chiu CC, Lin JJ, Yang ZY, Hwang WI, et al. Proteomic investigation of the sinulariolide-treated melanoma cells A375: effects on the cell apoptosis through mitochondrial-related pathway and activation of caspase cascade. Mar Drugs. 2013;11:2625–42.
12. Chiou HL, Hsieh YS, Hsieh MR, Chen TY. HCV E2 may induce apoptosis of Huh-7 cells via a mitochondrial-related caspase pathway. Biochem Biophys Res Commun. 2006;345:453–8.
13. Xiang SS, Wang XA, Li HF, Shu YJ, Bao RF, Zhang F, et al. Schisandrin B induces apoptosis and cell cycle arrest of gallbladder cancer cells. Molecules. 2014;19:13235–50.
14. Liu JY, Liu Z, Wang DM, Li MM, Wang SX, Wang R, et al. Induction of apoptosis in K562 cells by dicyclohexylammonium salt of hyperforin through a mitochondrial-related pathway. Chem Biol Interact. 2011;190:91–101.
15. Wang XA, Xiang SS, Li HF, Wu XS, Li ML, Shu YJ, et al. Cordycepin induces S phase arrest and apoptosis in human gallbladder cancer cells. Molecules. 2014;19:11350–65.
16. Xue C, Pasolli HA, Piscopo I, Gros DJ, Liu C, Chen Y, et al. Mitochondrial structure alteration in human prostate cancer cells upon initial interaction with a chemopreventive agent phenethyl isothiocyanate. Cancer Cell Int. 2014;14:30.
17. Choi BH, Kim W, Wang QC, Kim DC, Tan SN, Yong JW, et al. Kinetin riboside preferentially induces apoptosis by modulating Bcl-2 family proteins and caspase-3 in cancer cells. Cancer Lett. 2008;261:37–45.
18. Sinha K, Das J, Pal PB, Sil PC. Oxidative stress: the mitochondria-dependent and mitochondria-independent pathways of apoptosis. Arch Toxicol. 2013;87:1157–80.
19. Vladimirov YA, Proskurnina EV, Alekseev AV. Molecular mechanisms of apoptosis. Structure of cytochrome c-cardiolipin complex. Biochemistry. 2013;78:1086–97.
20. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature. 1995;376:37–43.
21. Tsai JR, Chong IW, Chen YH, Hwang JJ, Yin WH, Chen HL, et al. Magnolol induces apoptosis via caspase-independent pathways in non-small cell lung cancer cells. Arch Pharm Res. 2014;37:548–57.
22. Xu XY, Xia P, Yu M, Nie XC, Yang X, Xing YN, et al. The roles of REIC gene and its encoding product in gastric carcinoma. Cell Cycle. 2012;11:1414–31.
23. Li X, Cheung KF, Ma X, Tian L, Zhao J, Go MY, et al. Epigenetic inactivation of paired box gene 5, a novel tumor suppressor gene, through direct upregulation of p53 is associated with prognosis in gastric cancer patients. Oncogene. 2012;31:3419–30.
24. Li M, Lu J, Zhang F, Li H, Zhang B, Wu X, et al. Yes-associated protein 1 (YAP1) promotes human gallbladder tumor growth via activation of the AXL/MAPK pathway. Cancer Lett. 2014;355:201–9.
25. Sherr CJ. Cancer cell cycles. Science. 1996;274:1672–7.